oxybutynin has been researched along with flurbiprofen in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Goi, N; Ishii, T; Morishita, K; Saitoh, K; Taniguchi, A | 1 |
| Chen, Y; Cun, D; Fang, L; Guo, W; Liu, X; Quan, P; Song, W; Wang, Z | 1 |
| Hoshino, Y; Kamezawa, M; Matsumoto, H; Matsushita, I; Otsuka, N; Sasaki, S; Uebaba, K; Yamada, I; Yataba, I | 1 |
| Hoshino, Y; Matsumoto, H; Matsushita, I; Otsuka, N; Yataba, I | 1 |
| Hori, M; Ichihara, T; Kaku, S; Matsumoto, H; Mitani, A; Otsuka, N; Sekine, S; Sugimoto, M; Toda, Y | 1 |
| Fang, L; Li, S; Liu, C; Liu, X; Quan, P; Zhao, Y | 1 |
| Fukumoto, A; Hori, M; Kaku, S; Matsumoto, H; Tajima, K; Toda, Y | 1 |
| Ahmed, N; Khan, AU; Khan, D; Khan, S; Qindeel, M; Rehman, AU | 1 |
| Chu, T; Geng, D; Wang, C; Wang, H; Wang, J; Wu, C; Zhao, L | 1 |
1 review(s) available for oxybutynin and flurbiprofen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for oxybutynin and flurbiprofen
| Article | Year |
|---|---|
Plasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humans.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Female; Flurbiprofen; Healthy Volunteers; Humans; Male; Middle Aged; Osteoarthritis, Knee; Single-Blind Method; Synovial Membrane; Transdermal Patch; Young Adult | 2016 |
The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Contact; Female; Flurbiprofen; Humans; Male; Middle Aged; Osteoarthritis; Pain; Peptic Ulcer Hemorrhage; Prospective Studies; Transdermal Patch; Treatment Outcome | 2016 |
9 other study(ies) available for oxybutynin and flurbiprofen
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Delivery Systems; Flurbiprofen; Ketoprofen; Male; Permeability; Rats; Rats, Hairless; Skin Absorption; Tissue Distribution; Transdermal Patch | 2010 |
Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Cyclohexane Monoterpenes; Decanoates; Decanoic Acids; Disease Models, Animal; Drug Delivery Systems; Flurbiprofen; Male; Mice; Pain; Rabbits; Skin; Skin Absorption; Terpenes; Transdermal Patch | 2015 |
Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model.
Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Edema; Flurbiprofen; Humans; Male; Mycobacterium; Pain; Pain Threshold; Rats; Rats, Inbred Lew; Recombinant Proteins; Transdermal Patch | 2016 |
Time dependence of the enhancement effect of chemical enhancers: Molecular mechanisms of enhancing kinetics.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Drug Delivery Systems; Flurbiprofen; Kinetics; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Pharmaceutical Vehicles; Rats, Wistar; Skin; Skin Absorption; Transdermal Patch | 2017 |
Analgesic effect of S (+)-flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E
Topics: Analgesics; Animals; Arthritis, Experimental; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Flurbiprofen; Gait; Ketoprofen; Male; Phenylpropionates; Rats; Synovial Fluid; Transdermal Patch | 2018 |
Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis.
Topics: Administration, Cutaneous; Arthritis, Rheumatoid; Drug Delivery Systems; Flurbiprofen; Humans; Hydrogen-Ion Concentration; Nanoparticles; Skin; Skin Absorption; Transdermal Patch | 2020 |
Chiral 4-
Topics: Adjuvants, Pharmaceutic; Administration, Cutaneous; Animals; Drug Delivery Systems; Drug Liberation; Flurbiprofen; Male; Rabbits; Skin; Skin Absorption; Solubility; Stereoisomerism; Transdermal Patch | 2020 |